A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial

Autor: C. M. Sackley, C. Rick, P. Au, M. C. Brady, G. Beaton, C. Burton, M. Caulfield, S. Dickson, F. Dowling, M. Hughes, N. Ives, S. Jowett, P. Masterson-Algar, A. Nicoll, S. Patel, C. H. Smith, R. Woolley, C. E. Clarke, on behalf of the PD COMM Collaborative Group

Publikováno v: Trials, Vol 21, Iss 1, Pp 1-13 (2020)

Abstract Background Parkinson’s disease (PD) affects approximately 145,519 people in the UK. Speech impairments are common with a reported prevalence of 68%, which increase physical and mental demands during conversation, reliance on family and/or

Externí odkaz: https://doaj.org/article/d763e8b2aa3746758cc9d4cf69802b5c

Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)

Autor: J, Zitouni, A-C, Bursztejn, A, Belloni Fortina, A, Beauchet, V, Di Lernia, A, Lesiak, J, Thomas, Z, Topkarci, N, Murashkin, P, Brzezinski, T, Torres, A, Chiriac, C, Luca, T, McPherson, M, Akinde, A, Maruani, R, Epishev, H, Vidaurri de la Cruz, P C, Luna, M, Amy de la Bretêque, A, Lasek, E, Bourrat, M, Bachelerie, S, Mallet, M, Steff, A, Bellissen, I, Neri, E, Zafiriou, J M P A, van den Reek, E, Sonkoly, S K, Mahil, C H, Smith, C, Flohr, H, Bachelez, E, Mahé

Publikováno v: JEADV : Journal of the European Academy of Dermatology and Venereology, 36, 11, pp. 2076-2086
JEADV : Journal of the European Academy of Dermatology and Venereology, 36, 2076-2086

Contains fulltext : 287330.pdf (Publisher’s version ) (Closed access) BACKGROUND: The COVID-19 pandemic has raised questions regarding the management of chronic skin diseases, especially in patients on systemic treatments. Data concerning the use o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536ac2d1a979b41ec25684a02991dd1f
http://hdl.handle.net/11577/3451361

Fabrication of microstructured binary polymer brush 'corrals' with integral pH sensing for studies of proton transport in model membrane systems

Autor: Abdullah M. Alswieleh, Robert E. Ducker, Jeppe Madsen, Michaël L. Cartron, S. P. Armes, O. Al Jaf, C. H. Smith, Graham J. Leggett, C.N. Hunter

Publikováno v: Chemical Science. 9:2238-2251

Binary brush structures consisting of poly(cysteine methacrylate) (PCysMA) “corrals” enclosed within poly(oligoethylene glycol methyl ether methacrylate) (POEGMA) “walls” are fabricated simply and efficiently using a two-step photochemical pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28457311860777be0f1cb82813ca34e4
https://doi.org/10.1039/c7sc04424k

Clinical outcomes in patients on secukinumab (Cosentyx

Autor: A V, Sears, C, Szlumper, K W, Liu, C H, Smith, J N W N, Barker, A E, Pink

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV. 33(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::76931dd189fdb1eb1e095b953fa9056d
https://pubmed.ncbi.nlm.nih.gov/30198598

Denosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases

Autor: Nick Boyd, Andrew C H Smith, Michael O'Halloran

Publikováno v: Australian Dental Journal. 59:516-519

Denosumab (Amgen, Thousand Oaks, California, USA) is a new bone antiresorptive agent used in patients with osteoporosis or metastatic cancer to the bones. As with the bisphosphonates that are used as antiresorptive medications, denosumab has been ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe719e0049ea3aa98e5e0fc17a4c514
https://doi.org/10.1111/adj.12217